the aid library

LIST OPTIONS

Filter

7546

Reflection on inclusive health services in northwest Syria (NWS)

Islamic Relief (2022) CC

After a decade of crisis, Syria remains one of the world’s most complex humanitarian crises. Continued hostilities, new and protracted displacement, increased returns and the sustained destruction of communities have impacted Syrians’ lives and futures in a devastating way. The 2021 Humanitarian... more

Download (516)

View PDF (694)

Higiene de las manos

Nurses International (2016) C1

OBJETIVOS •Definir la Higiene de manos y las infecciones adquiridas en los hospitales (HAIs). •Describir el impacto negativo de las HAIs en pacientes dados de alta. •Discutir cómo la higiene de manos puede prevenir los HAIs. •Identificar las barreras para el cumplimiento de la higiene d... more

Download (414)

View PDF (370)

Care, cleaning and disinfection of invasive mechanical ventilators
recommended

World Health Organization WHO (2022) C_WHO

During ventilation and between patients Always read and follow the instructions and recommendations of the manufacturer`s manual Consumables associated with oxygen delivery are generally intended as single use devices, and should be treated as infectious material and disposed of accordingly. Dispo... more

Download (174)

View PDF (348)

Hablamos de Chagas: Relatos y trazos para pensar un problema complejo

Sanmartino, M. Hablamos De Chagas (2013) CC

“¿De qué hablamos cuando hablamos de Chagas? Estrategias y recursos didácticos para abordar el tema en diferentes contextos educativos” es un proyecto de extensión de la Universidad Nacional de La Plata a través del cual buscamos promover el abordaje de la problemática del Chagas, desd... more

Download (465)

View PDF (693)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (600)

View PDF (803)

Interim National Guidelines for Monkeypox Outbreak Response

Federal Ministry of Health - Nigeria Centre for Disease Contro (2017) C2

This document provides information and recommendations for action, based on the current available knowledge around monkeypox. It is a first draft which will be updated in light of evolving evidence and additional information as they become available.

Download (368)

View PDF (685)

Kangaroo mother care: a practical guide
recommended

World Health Organization WHO (2003) CC

Kangaroo mother care is a method of care of preterm infants. The method involves infants being carried, usually by the mother, with skin-to-skin contact. This guide is intended for health professionals responsible for the care of low-birth-weight and preterm infants. Designed to be adapted to local ... more

Download (1926)

View PDF (6336)

Hand Hygiene Technical Reference Manual

World Health Organization WHO (2009) CC

A manual to train health-care workers on practising, teaching and observing hand hygiene.

Download (596)

View PDF (772)

Epidemic meningitis surveillance in the African meningitis belt

World Health Organization WHO (2014) C_WHO

External Link

Tuberkulosescreening bei asylsuchenden Kindern und Jugendlichen < 15 Jahren in Deutschland

Nicole Ritz, Folke Brinkmann, Cornelia Feiterna-Sperling. et al. Springer (2015) C2

Stellungnahme der Arbeitsgruppe AWMFLeitlinie Tuberkulose im Kindes- und Jugendalter: Diagnostik, Prävention und Therapie unter Federführung der Deutschen Gesellschaft für Pädiatrische Infektiologie. Monatsschr Kinderheilkd 2015 · 163:1287–1292 DOI 10.1007/s00112-015-0007-5 © Deutsche Gesel... more

Download (861)

View PDF (1479)

Prevenção da potencial transmissão do vírus Zika por via sexual
recommended

Organização Mundial da Saùde (2016) C_WHO

Actualização das orientações provisórias 7 de Junho de 2016

Download (823)

View PDF (816)

Infection Prevention and control and health care waste management for waste handlers

USAID, AIDS Free Nigeria (2016) C1

AIDS Free Nigeria Training Manual

Download (418)

View PDF (625)

Integrated Management of Neonatal and Childhood Illness - Identify Treatment for the Sick Child (Module 6/9)

World Health Organization WHO; UNICEF (2009) C_WHO

Download (302)

View PDF (802)

Provisional CDC Guidelines for the Use and Safety Monitoring of Bedaquiline Fumarate (Sirturo) for the Treatment of Multidrug-Resistant Tuberculosis

Centers for Disease Control and Prevention (2013) C_CDC

MMWR: Recommendations and Reports / Vol. 62 / No. 9 Morbidity and Mortality Weekly Report October 25, 2013

Download (341)

View PDF (753)

Visual Impairments, including Blindness

National Dissemination Center for Children with Disabilities (NICHCY) (2012) C2

Disability Fact Sheet #13 (FS13)

Download (494)

View PDF (805)

Guidelines on second-and third-line medicines and type of insulin for the control of blood glucose levels in non-pregnant adults with diabetes mellitus

World Health Organization WHO (2018) C_WHO

The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I... more

Download (1102)

View PDF (2382)

Technical note for Ebola virus disease preparedness planning for entry screening at airports, ports and land crossings

World Health Organization (2014)

Download (246)

View PDF (271)

Identifying Early Adopters of COVID-19 Vaccines in Latin America

Arrieta, A.; A. García-Prado, J.P. Sarmiento, et al. Florida International University (2021) CC

COVID-19 vaccine hesitancy is currently one of the main obstacles to worldwide herd immunity and socioeconomic recovery. Because vaccine coverage can vary between and within countries, it is important to identify sources of variation so that policies can be tailored to different population groups. ... more

Download (609)

View PDF (2203)

International Health Emergency Response Plan- Marburg Virus Disease

World Health Organization WHO (2017) C_WHO

On 17 October 2017, the Ugandan Ministry of Health notified WHO of a confirmed Marburg outbreak of Marburg Virus disease (MVD) in Kween district, Eastern Uganda. The outbreak was officially declared by the Ministry of health on 19 October 2017. As of 7 November, four cases of MVD have been reported... more

Download (447)

View PDF (529)

Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV. Policy brief
recommended

World Health Organization WHO (2022) C_WHO

Cryptococcal disease, particularly cryptococcal meningitis is a significant cause of morbidity and mortality among people living with HIV with advanced HIV disease. It is estimated that it is responsible for nearly 19% of AIDS-related mortality, second only to tuberculosis. Rapid screening, diagnosi... more

Care, cleaning and disinfection of invasive mechanical ventilators recommended

Kangaroo mother care: a practical guide recommended

Prevenção da potencial transmissão do vírus Zika por via sexual recommended

Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV. Policy brief recommended

Care, cleaning and disinfection of invasive mechanical ventilators
recommended

Kangaroo mother care: a practical guide
recommended

Prevenção da potencial transmissão do vírus Zika por via sexual
recommended

Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV. Policy brief
recommended